Prior Antibodies to Infliximab or Adalimumab Are Related to Immunogenicity to Vedolizumab in Patients With Inflammatory Bowel Disease

被引：5
|
作者：
Papamichael, Konstantinos [1 ,7 ]
Vande Casteele, Niels [2 ]
Abraham, Bincy P. [3 ]
Ritter, Timothy [4 ]
Jain, Anjali [5 ]
Cheifetz, Adam S. [6 ]
机构：
[1] Beth Israel Deaconess Med Ctr, Ctr Inflammatory Bowel Dis, Boston, MA USA
[2] Univ Calif San Diego, Dept Med, La Jolla, CA USA
[3] Houston Methodist Hosp, Dept Med, Houston, TX USA
[4] GI Alliance Res, Southlake, TX USA
[5] Prometheus Labs, San Diego, CA USA
[6] Beth Israel Deaconess Med Ctr, Ctr Inflammatory Bowel Dis, Boston, MA USA
[7] Beth Israel Deaconess Med Ctr, Ctr Inflammatory Bowel Dis, 330 Brookline Ave, Boston, MA 02215 USA
来源：
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY | 2023年 / 21卷 / 11期
关键词：
FAILURE;
D O I：
10.1016/j.cgh.2022.10.037
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：2978 / +
页数：5
相关论文
共 50 条
  • [21] Infusion administration billing for vedolizumab and infliximab in inflammatory bowel disease
    Null, Kyle
    Kumar, Varun
    Lissoos, Trevor
    Luo, Michelle
    JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (11) : 1102 - 1109
  • [22] Adalimumab or Infliximab for the Treatment of Inflammatory Bowel Disease Patients: Which Is More Effective?
    Carrillo-Ramos, Maria Jesus
    Duarte-Chang, Calixto
    Maldonado-Perez, Belen
    Beltran-Castano, Rocio
    Castro-Laria, Luisa
    Argueelles-Arias, Federico
    Benitez-Roldan, Antonio
    Caunedo-Alvarez, Angel
    Pellicer-Bautista, Francisco
    Herrerias, Juan M.
    GASTROENTEROLOGY, 2014, 146 (05) : S196 - S196
  • [23] INFLIXIMAB AND VEDOLIZUMAB SHOW A DIFFERENT EFFECT ON CLOT FORMATION IN INFLAMMATORY BOWEL DISEASE PATIENTS
    Detrez, Iris
    Ballet, Vera
    Peeters, Miet
    Van Assche, Gert A.
    Vermeire, Severine
    Ferrante, Marc
    Gils, Ann
    GASTROENTEROLOGY, 2018, 154 (06) : S362 - S363
  • [24] SB5 shows cross-immunogenicity to adalimumab but not infliximab: results in patients with inflammatory bowel disease or rheumatoid arthritis
    Goncalves, Joao
    Myung, Gihyun
    Park, MinJeong
    Jeong, Deokyoon
    Ghil, Jeehoon
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2019, 12
  • [25] Infliximab and vedolizumab show a different effect on clot formation in inflammatory bowel disease patients
    Detrez, I.
    Ballet, V.
    Peeters, M.
    Van Assche, G.
    Vermeire, S.
    Ferrante, M.
    Gils, A.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S349 - S350
  • [26] Pharmacokinetics, pharmacodynamics, and immunogenicity of biosimilar infliximab in pediatric patients with inflammatory bowel disease
    Dipasquale, V.
    Alibrandi, A.
    Pellegrino, S.
    Ramistella, V.
    Romano, C.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1618 - I1618
  • [27] The effects of pregnancy on the pharmacokinetics of infliximab and adalimumab in inflammatory bowel disease
    Seow, C. H.
    Leung, Y.
    Vande Casteele, N.
    Afshar, E. Ehteshami
    Tanyingoh, D.
    Bindra, G.
    Stewart, M. J.
    Beck, P. L.
    Kaplan, G. G.
    Ghosh, S.
    Panaccione, R.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (10) : 1329 - 1338
  • [28] Vedolizumab Immunogenicity With Long-Term or Interrupted Treatment of Patients With Inflammatory Bowel Disease
    Wyant, Timothy
    Yang, Lili
    Lirio, Richard A.
    Rosario, Maria
    JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 61 (09): : 1174 - 1181
  • [29] Antibodies Against Infliximab Are Associated With Increased Risk of Anti-Adalimumab Antibody Development in Patients With Inflammatory Bowel Disease
    Frederiksen, Madeline T.
    Ainsworth, Mark A.
    Brynskov, Jorn
    Thomsen, Ole
    Bendtzen, Klaus
    Steenholdt, Casper
    GASTROENTEROLOGY, 2014, 146 (05) : S238 - S238
  • [30] Antibodies against infliximab are associated with increased risk of anti-adalimumab antibody development in patients with inflammatory bowel disease
    Frederiksen, M. T.
    Ainsworth, M. A.
    Brynskov, J.
    Thomsen, O. O.
    Bendtzen, K.
    Steenholdt, C.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S300 - S300
12345